Literature DB >> 17301972

Association of essential thrombocythemia and chronic lymphocytic leukemia: absence of the V617F JAK2 mutation in the lymphoid compartment.

Laurent Henry, Serge Carillo, Eric Jourdan, Anne Arnaud, Sophie Brun, Thierry Lavabre-Bertrand.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17301972     DOI： 10.1002/ajh.20870

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  9 in total

1.  Concomitant Myeloproliferative and Lymphoid Neoplasms in Two Patients Positive for JAK2 V617F Mutation. Case Report and Literature Review.

Authors:  Adrian P Trifa; Andrei Cucuianu; Radu A Popp; Mariana Paţiu; Cristina Selicean; Mariela S Militaru; Ioan V Pop
Journal:  Indian J Hematol Blood Transfus       Date:  2013-06-14       Impact factor: 0.900

2.  Concomitant myeloproliferative and lymphoproliferative neoplasms, distinct progenitors: A case report and review of the literature.

Authors:  Filipa Mousinho; Paula Sousa E Santos; Ana P Azevedo; José Manuel Pereira; Raquel Lemos; Sónia Matos; João Faro Viana; Fernando Lima
Journal:  Mol Clin Oncol       Date:  2018-07-19

3.  Concomitant JAK2 V617F-positive polycythemia vera and B-cell chronic lymphocytic leukemia in three patients originating from two separate hematopoietic stem cells.

Authors:  Sabina Swierczek; Jitka Nausova; Jaroslav Jelinek; Enli Liu; Paul Roda; Jana Kucerova; Marie Jarosova; Helena Urbankova; Karel Indrak; Josef T Prchal; Vladimir Divoky
Journal:  Am J Hematol       Date:  2012-12-24       Impact factor: 10.047

4.  Zap-70 positive chronic lymphocytic leukemia co-existing with Jak 2 V671F positive essential thrombocythemia: a common defective stem cell?

Authors:  Piotr Tabaczewski; Sushani Nadesan; Seah H Lim
Journal:  Leuk Res       Date:  2008-10-11       Impact factor: 3.156

5.  Simultaneous presentation of JAK2 V617F mutation-related essential thrombocythemia and B-cell chronic lymphocytic leukemia.

Authors:  Guido D'Angelo; Anna Maria Hotz; Fabrizio Ciambelli; Sergio Pauli
Journal:  Blood Res       Date:  2014-06-25

6.  Acute Lymphoblastic Leukemia Arising in CALR Mutated Essential Thrombocythemia.

Authors:  Stephen E Langabeer; Karl Haslam; David O'Brien; Johanna Kelly; Claire Andrews; Ciara Ryan; Richard Flavin; Patrick J Hayden; Christopher L Bacon
Journal:  Case Rep Hematol       Date:  2016-01-21

7.  Expression of CD markers in JAK2V617F positive myeloproliferative neoplasms: Prognostic significance.

Authors:  Saeid Shahrabi; Ali Ehsanpour; Somayyeh Heidary; Mohammad Shahjahani; Masumeh Maleki Behzad
Journal:  Oncol Rev       Date:  2018-10-02

8.  JAK2 V617F detected in two B-cell chronic lymphocytic leukemia patients without coexisting Philadelphia chromosome-negative myeloproliferative neoplasms: A report of two cases.

Authors:  Yi-Ning Yang; You-Wen Qin; Chun Wang
Journal:  Oncol Lett       Date:  2014-05-22       Impact factor: 2.967

9.  Coexistence of Myeloid and Lymphoid Neoplasms: A Single-Center Experience.

Authors:  Anthi Bouchla; Thomas Thomopoulos; Sotirios Papageorgiou; Panagiotis Tsirigotis; Efthymia Bazani; Konstantinos Gkirkas; Diamantina Vasilatou; Eirini Glezou; Georgia Stavroulaki; Konstantinos Gkontopoulos; George Dimitriadis; Vasiliki Pappa
Journal:  Adv Hematol       Date:  2019-11-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.